Skip to content
drillr.ai

ASPI

ASP Isotopes Inc. Common Stock

NASDAQ · USBasic MaterialsChemicals
$3.89+0.39%

Price as of Jul 20, 2026

ASPI news

ASP Isotopes Inc. Common Stock news

A server-rendered, paginated timeline of the latest available company news.

  1. Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company

    Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company Noble Africa was created to unlock the value of Renergen's Virginia Gas Project through a public company focused on helium and LNG Learn why the Virginia Gas Project is positioned to become one of the world's most strategic helium developments as global supply tightens and demand accelerates ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or “ASPI”), an advanced materials comp

    Business Wire ·

  2. ASP Isotopes Announces Agreements to Exchange Certain QLE Convertible Notes for ASPI Common Stock

    DALLAS, July 15, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASPI", the "Company" or “we”) today announced that ASPI and Quantum Leap Energy LLC ("QLE"), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, have entered into separate, individually negotiated private exchange agreements (the “Exchange Agreements”) with certain holders of QLE’s outstanding convertible pr

    Globe Newswire ·

  3. Alliance Entertainment and ASP Isotopes Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

    ORLANDO, FL / ACCESS Newswire (https://www.accessnewswire.com/) / June 26, 2026 / RedChip Companies will air interviews with Alliance Entertainment Holding Corp. (Nasdaq:AENT) and ASP Isotopes, Inc. (Nasdaq:ASPI) on the RedChip Small Stocks, Big Money(™) show, a sponsored program on Bloomberg TV, this Saturday, June 27, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S. Access the interviews in their entirety at: * AENT: https://www.redchip.c

    ACCESSWIRE ·

  4. ASP Isotopes Announces Proposed Merger of Noble Africa with ENDRA Life Sciences and Approximately $50 Million Concurrent Private Placement Financing

    Combination, if successful, would establish Noble Africa as a Nasdaq-listed, helium platform for Renergen’s Virginia Gas Project Listing expected to provide investors with direct exposure to one of the few publicly traded helium development assets globally, at a time of tightening supply Concurrent private placement expected to generate approximately $50 million in gross proceeds to support project development DALLAS and ANN ARBOR, Mich., June 25, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (N

    Globe Newswire ·

  5. ASP Isotopes Inc. Announces that a Subsidiary of Renergen Limited Has Entered into its First Take-or-Pay Contract for the Supply of Contained Helium to be Produced at the Virginia Gas Project in South Africa

    Tetra4, a subsidiary of Renergen and the developer of the Virginia Gas Project, has entered into its first take-or-pay contract to supply contained helium to an Asian industrial gases company, establishing a multi-year contracted cash flow supporting Phase 1 commercial operations, which remain targeted for the third quarter of 2026. The helium sale and purchase agreement, which is a five-year take-or-pay contract, is priced at greater than $600/MCF of contained helium. The Company is in discus

    Globe Newswire ·

  6. Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ASP Isotopes Inc. (ASPI) And Encourages Shareholders to Reach Out

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / May 21, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI. (https://bgandg

    ACCESSWIRE ·

  7. Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ASP Isotopes Inc. (ASPI) and Encourages Shareholders to Learn More About the Investigation

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / May 19, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI. (https://bgandg

    ACCESSWIRE ·

  8. ASP Isotopes Inc. (ASPI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / May 12, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI. (https://bgandg

    ACCESSWIRE ·

  9. ASP Isotopes Inc. (ASPI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / April 30, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI. (https://bgan

    ACCESSWIRE ·

  10. ASP Isotopes Inc. Provides Business Update

    First Commercial Shipments Expected Across Multiple Isotopes in 2026 Expect to Obtain Helium Phase 1 Nameplate Capacity in Q3 2026 EBITDA Target of Greater Than $300 Million in 2031 Cash, Cash Equivalents and Short-Term Marketable Securities of $333 million as of December 31, 2025 Business Update Conference Call Scheduled for 8:00 AM ET on April 13, 2026 DALLAS, April 13, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials compa

    Globe Newswire ·

  11. Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders?

    Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, April 9, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK, April 9, 2026 /P

    PR Newswire ·

  12. ASP Isotopes Inc. (ASPI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / April 9, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI. (https://bgand

    ACCESSWIRE ·

  13. Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf

    PHILADELPHIA, March 30, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) Class Action Survives Motion to Dismiss WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI). The investigation concerns whether the Company and certain of its officers and directors violated the federal securities laws and breached their fiduciary duties by making materially false and misleading statements regar

    Globe Newswire ·

  14. Grabar Law Office Investigates Claims on Behalf of Investors of ASP Isotopes Inc. (ASPI) as Class Action Survives Motion to Dismiss

    Philadelphia, Pennsylvania--(Newsfile Corp. - March 26, 2026) - What is Happening? Grabar Law Office is investigating claims on behalf of shareholders of ASP Isotopes Inc. ("ASP Isotopes" or the "Company") (NASDAQ: ASPI). The investigation concerns whether the Company and certain of its officers breached their fiduciary duties. If you purchased or otherwise acquired ASP Isotopes Inc. (NASDAQ: ASPI) securities prior to September 26, 2024 and still hold shares today, you can seek corporate reforms

    Newsfile Corp ·

  15. ASP Isotopes Announces Strategic Collaboration Between Quantum Leap Energy and University of Bristol to Design Advanced Laser Research Facility

    DALLAS, March 24, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that a UK subsidiary of Quantum Leap Energy LLC (“QLE”), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, has commenced a strategic collaboration with the University of Bristol for the design of a state-of-the-art lithium laser research facility in the UK. This collaboration marks

    Globe Newswire ·

  16. Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf

    PHILADELPHIA, March 23, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) Class Action Survives Motion to Dismiss WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI). The investigation concerns whether the Company and certain of its officers and directors violated the federal securities laws and breached their fiduciary duties by making materially false and misleading statements regar

    Globe Newswire ·

  17. Bronstein, Gewirtz & Grossman, LLC Encourages ASP Isotopes Inc. (ASPI) Stockholders to Inquire about Securities Investigation

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / March 22, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI. (https://bgan

    ACCESSWIRE ·

  18. Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR): Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your Behalf

    PHILADELPHIA, March 18, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) Class Action Survives Motion to Dismiss WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI). The investigation concerns whether the Company and certain of its officers and directors violated the federal securities laws and breached their fiduciary duties by making materially false and misleading statements regar

    Globe Newswire ·

  19. Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ASP Isotopes Inc. (ASPI) And Encourages Investors to Reach Out

    NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / March 17, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ASPI. (https://bgan

    ACCESSWIRE ·

  20. Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Camping World Holdings, Inc. (NYSE: CWH); Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office Investigates Claims on Your Behalf

    PHILADELPHIA, March 16, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) Class Action Survives Motion to Dismiss What is Happening? Grabar Law Office is investigating claims on behalf of shareholders of ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI). The investigation concerns whether the Company and certain of its officers and directors violated the federal securities laws and breached their fiduciary duties by making materially false and misleading statements regar

    Globe Newswire ·